T42.0X1A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Poisoning by hydantoin derivatives, accidental, init The 2021 edition of ICD-10-CM T42.0X1A became effective on October 1, 2020.
Elevated partial thromboplastin time; Elevated prothrombin time; Partial thromboplastin time increased; Prothrombin time increased; ICD-10-CM R79.1 is grouped within Diagnostic Related Group(s) (MS-DRG v 38.0): 947 Signs and symptoms with mcc; 948 Signs and symptoms without mcc; Convert R79.1 to ICD-9-CM. Code History
Elevated amylase; Elevated cpk; Hyperamylasemia; Increased creatine kinase level; Macroamylasemia; Serum amylase raised; ICD-10-CM R74.8 is grouped within Diagnostic Related Group(s) (MS-DRG v 38.0): 947 Signs and symptoms with mcc; 948 Signs and symptoms without mcc; Convert R74.8 to ICD-9-CM. Code History
Diagnosis Index entries containing back-references to R74.8: Abnormal, abnormality, abnormalities - see also Anomaly serum level (of) enzymes R74.9 ICD-10-CM Diagnosis Code R74.9 Elevated, elevation liver function test R79.89 ICD-10-CM Diagnosis Code R79.89
Z51. 81 Encounter for therapeutic drug level monitoring - ICD-10-CM Diagnosis Codes.
ICD-10-CM Diagnosis Code Z79 Z79.
ICD-10 code Z79. 899 for Other long term (current) drug therapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 code R68. 89 for Other general symptoms and signs is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
ICD-10 code Z51. 81 for Encounter for therapeutic drug level monitoring is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10-PCS GZ3ZZZZ is a specific/billable code that can be used to indicate a procedure.
The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes. Because Plaquenil does not have its own specific category, clinicians should use Z79. 899—Other Long Term (Current) Drug Therapy.
Code R53. 83 is the diagnosis code used for Other Fatigue. It is a condition marked by drowsiness and an unusual lack of energy and mental alertness. It can be caused by many things, including illness, injury, or drugs.
ICD-10 code R79. 89 for Other specified abnormal findings of blood chemistry is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
R68. 89 is a VALID/BILLABLE ICD10 code, i.e it is valid for submission for HIPAA-covered transactions. R68. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10 code Z00. 01 for Encounter for general adult medical examination with abnormal findings is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
From ICD-10: For encounters for routine laboratory/radiology testing in the absence of any signs, symptoms, or associated diagnosis, assign Z01. 89, Encounter for other specified special examinations.
Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues 1 R89.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 Short description: Abn lev drug/meds/biol subst in specimens from oth org/tiss 3 The 2021 edition of ICD-10-CM R89.2 became effective on October 1, 2020. 4 This is the American ICD-10-CM version of R89.2 - other international versions of ICD-10 R89.2 may differ.
The 2022 edition of ICD-10-CM R89.2 became effective on October 1, 2021.